Ninth biannual report of the cochrane haematological malignancies group-focus on hematopoietic growth factors

Journal of the National Cancer Institute

Volumn 101, Issue 9, 2009, Pages

  Skoetz, Nicole ^a   Weingart, Olaf ^a   Monsef, Ina ^a   Bauer, Kathrin ^a   Brillant, Corinne ^a   Herbst, Christine ^a   Kluge, Sabine ^a   Engert, Andreas ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; ERYTHROPOIETIN; HEMOPOIETIC GROWTH FACTOR; IMMUNOGLOBULIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

BLOOD DISEASE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL PROTOCOL; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IRON DEFICIENCY ANEMIA; LUNG TUMOR; LYMPHOMA; MALE; METHODOLOGY; MORTALITY; MULTICENTER STUDY; NEOPLASM; NEUTROPENIA; NONHODGKIN LYMPHOMA; POLYCYTHEMIA VERA; RANDOMIZED CONTROLLED TRIAL; REVIEW; SMALL CELL CARCINOMA; STANDARD; STATISTICAL ANALYSIS; SURVIVAL; THROMBOCYTHEMIA; TREATMENT OUTCOME;

ANEMIA, HYPOCHROMIC; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, SMALL CELL; CLINICAL PROTOCOLS; DATA INTERPRETATION, STATISTICAL; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FILGRASTIM; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GRANULOCYTES; HEMATINICS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUNG NEOPLASMS; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MALE; MULTICENTER STUDIES AS TOPIC; NEOPLASMS; NEUTROPENIA; PLATELET AGGREGATION INHIBITORS; POLYCYTHEMIA VERA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SURVIVAL ANALYSIS; THROMBOCYTHEMIA, ESSENTIAL; TREATMENT OUTCOME;

EID: 65549150709     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp091     Document Type: Article

References (14)

1. Aapro M, Leonard RC, Barnadas A, et al. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline-And/or taxane-based chemotherapy: Results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study. J Clin Oncol 2008;26(4):592-598. (Pubitemid 351264353)
2. Pirker R, Ramlau RA, Schuette W, et al. Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide. J Clin Oncol 2008;26(14):2342-2349.
3. Smith RE, Aapro MS, Ludwig H, Pinter T. Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. J Clin Oncol 2008;26(7):1040- 1050.
4. Balducci L, Al Halawani H, Charu V, et al. Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim. Oncologist 2007;12(12):1416-1424.
5. Russell N, Mesters R, Schubert J, et al. A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy. Haematologica 2008;93(3Uh III Zs.76):405-412. (Pubitemid 351398642)
6. Squizzato A, Romualdi E, Middeldorp S. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia. Cochrane Database Syst Rev 2008:2. CD006503.
7. Quellmann S, Schwarzer G, Hübel K, Greb A, Engert A, Bohlius J. Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplan. Cochrane Database Syst Rev. 2008:3. CD004885.
8. Bohlius J, Herbst C, Reiser M, Schwarzer G, Engert A. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Cochrane Database Syst Rev. 2008:4. CD003189.
9. Raanani P, Gafter GA, Paul M, Ben Bassat I, Leibovici L, Shpilberg O. Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation. Cochrane Database Syst Rev. 2008:4. CD006501.
10. Herbst C, Naumann F, Kruse E, et al. Prophylactic antibiotics and G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy- protocol. Cochrane Database Syst Rev. 2008:2. CD007107.
11. Rehan FA, Bohlius J, Brillant C, Knauel I, Specht L, Engert A. Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin Lymphoma-protocol. Cochrane Database Syst Rev. 2008:2. CD007110.
12. Bohlius J, Trelle S, Weingart O, et al. Erythropoietin or darbepoetin for patients with cancer-meta-Analysis based on individual patient data-protocol. Cochrane Database Syst Rev. 2008:3. CD007303.
13. Meerpohl JJ, Antes G, Rücker G, et al. Deferasirox for managing iron overload in patients with myelodysplastic syndrome-protocol. Cochrane Database Syst Rev. 2008:4. CD0077461.
14. Gurion R, Gafter-Gvili A, Paul M, et al. Hematopoietic growth factors in the treatment of acquired aplastic anemia-protocol. Cochrane Database Syst Rev. 2008:4. CD007466.